Effects of phytoestrogens on DNA synthesis in MCF-7 cells in the presence of estradiol or growth factors

Nutrition and Cancer

Volumn 31, Issue 2, 1998, Pages 90-100

  Wang, Chuanfeng ^a   Kurzer, Mindy S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APIGENIN; CHRYSIN; COUMESTROL; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GENISTEIN; GROWTH FACTOR; INSULIN; LUTEOLIN; PHYTOESTROGEN; TAMOXIFEN;

ARTICLE; CELL STRAIN MCF 7; CONTROLLED STUDY; DNA SYNTHESIS; DRUG EFFECT; DRUG RESEARCH; DRUG SCREENING; HORMONE ACTION; HUMAN; HUMAN CELL;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0031783890     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589809514686     Document Type: Article

References (56)

1. Adlercreutz, H, Fotsis, T, Heikkinen, R, Dwyer, JT, Woods, M, et al.: Excretion of the lignons enterolactone and enterodiol and of equol in omnivorous and vegetarian postmenopausal women and in women with breast cancer. Lancet 2, 1295-1299, 1982.
2. Adlercreutz, H, Fotsis, T, Bannwart, C, Wahala, K, Makela, T, et al.: Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on habitual diets. J Steroid Biochem 25, 791-797, 1986.
3. Martin, PM, Horwiz, KB, Ryan, DS, and McGuire, WL: Phytoestrogen interaction with estrogen receptors in human breast cancer cells. Endocrinology 103, 1860-1867, 1978.
4. Markaverich, BM, Roberts, RR, Alejandro, MA, Johnson, GA, Middleditch, BS, et al.: Bioflavonoid interaction with rat uterine type II binding sites and cell growth inhibition. J Steroid Biochem Mol Biol 30, 71-78, 1988.
5. Adlercreutz, H, Mousavi, Y, Clark, J, Hockerstedt, K, Hamalainen, E, et al.: Dietary phytoestrogens and cancer: in vitro and in vivo studies. J Steroid Biochem Mol Biol 41, 331-337, 1992.
6. Miksicek, RJ: Commonly occurring plant flavonoids have estrogenic activity. Mol Pharmacol 44, 37-43, 1993.
7. Miksicek, RJ: Estrogenic flavonoids: structural requirements for biological activity. Proc Soc Exp Biol Med 208, 44-50, 1995.
8. Whitten, PL, Russel, E, and Naftolin, F: Effects of a normal, human-concentration, phytoestrogen diet on rat uterine growth. Steroids 57, 98-106, 1992.
9. Wang, TTY, Sathyamoorthy, N, and Phang, JM: Molecular effect of genistein on estrogen receptor mediated pathways. Carcinogenesis 17, 271-275, 1996.
10. Sathyamoorthy, N, Wang, TTY, and Phang, JM: Stimulation of pS2 expression by diet-derived compounds. Cancer Res 79, 957-961, 1994.
11. Wang, C, and Kurzer, MS: Phytoestrogen concentration determines effects on DNA synthesis in human breast cancer cells. Nutr Cancer 28, 236-275, 1997.
12. Makela, S, Davis, VL, Tally, WC, Korkman, J, Salo, L, et al.: Dietary estrogens act through estrogen receptor-mediated processes and show no antiestrogenicity in cultured breast cancer cells. Environ Health Perspect 102, 572-578, 1994.
13. Steinmetz, K, and Potter, JD: Vegetables, fruit, and cancer. II Mechanisms. Cancer Causes Control 2, 421-442, 1991.
14. Adlercreutz, H, Bannwart, C, Wahala, K, Makela, T, Brunow, G, et al.: Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens. J Steroid Biochem Mol Biol 44, 147-153, 1993.
15. Campbell, DR, and Kurzer, MS: Flavonoid inhibition of aromatase enzyme activity in human preadipocytes. J Steroid Biochem Mol Biol 46, 381-388, 1993.
16. Wang, C, Makela, T, Hase, T, Adlercreutz, H, and Kurzer, MS: Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes. J Steroid Biochem Mol Biol 50, 205-212, 1994.
17. Zava, DT, and Duwe, G: Estrogenic and antiproliferative properties of genistein and other flavonoids in human breast cancer cells in vitro. Nutr Cancer 27, 31-40, 1997.
18. Peterson, G, and Barnes, S: Genistein inhibits both estrogen-and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ 7, 1345-1351, 1996.
19. Folman, Y, and Pope, GS: The interaction in the immature mouse of potent oestrogens with coumestrol, genistein and other utero-vaginotrophic compounds of low potency. J Endocrinol 34, 215-225, 1966.
20. Whitten, PL, Russell, E, and Naftolin, F: Influence of phytoestrogen diets on estradiol action in the rat uterus. Steroids 59, 443-449, 1994.
21. Lamartiniere, CA, Moore, J, Brown, NM, Thompson, R, Hardin, MJ, et al.: Genistein suppresses mammary cancer in rats. Carcinogenesis 16, 2833-2840, 1995.
22. Murrill, WB, Brown, NM, Zhang, JX, Manzolillo, PA, Barnes, S, et al.: Prepubertal genistein exposure suppresses mammary cancer and enhances gland differentiation in rats. Carcinogenesis 17, 1451-1457, 1996.
23. Santell, RC, Chang, YC, Nair, MG, and Helferich, WG: Dietary genistein exerts estrogenic effects upon the uterus, mammary gland and the hypothalamic/pituitary axis in rats. J Nutr 127, 263-269, 1997.
24. McMichael-Phillips, DF, Harding, C, Morton, M, Potten, CS, and Bundred, NJ: The effects of soy supplementation on epithelial proliferation in the normal human breast (abstr). Second International Symposium on the Role of Soy in Preventing and Treating Chronic Disease, Sept 1996, p 35.
25. Petrakis, NL, Barnes, S, King, EB, Lowenstein, J, Wiencke, J, et al.: Stimulatory influence of soy protein isolate on breast secretion in preand postmenopausal women. Cancer Epidemiol Biomarkers Prev 5, 785-794, 1996.
26. Akiyama, T, Ishida, J, Nakagawa, S, Ogawara, H, Watanabe, S, et al.: Genistein, a specific inhibitor of tyrosine-specific tyrosine kinases. J Biol Chem 262, 5592-5595, 1987.
27. Davidai, G, Lee, A, Schvartz, I, and Hazum, E: PDGF induces tyrosine phosphorylation in osteoblast-like cells: relevance to mitogenesis. Am J Physiol 263, E205-E209, 1992.
28. Kawase, T, Orikasa, M, Ogata, S, and Burns, DM: Protein tyrosine phosphorylation induced by epidermal growth factor and insulin-like growth factor I in a rat clonal dental pulp cell line. Arch Oral Biol 40, 921-929, 1995.
29. Weernink, PAO, Verheul, E, Kerkhof, E, van Veelen, CWM, and Rijksen, G: Inhibitors of protein tyrosine phosphorylation reduce the proliferation of two human glioma cell lines. Neurosurgery 38, 108-114, 1996.
30. Peterson, G: Evaluation of the biochemical targets of genistein in tumor cells. J Nutr 125, 784s-789s, 1995.
31. Adlercreutz, CHT, Goldin, BR, Gorbach, SL, Hockerstedt, KAV, Watanabe, S, et al.: Soy phytoestrogen intake and cancer risk. J Nutr 125 Suppl 3, 757s-770s, 1995.
32. Xu, X, Wang, H-J, Murphy, PA, Cook, L, and Hendrich, S: Daidzein is a more bioavailable soymilk isoflavone than is genistein in adult women. J Nutr 124, 825-832, 1994.
33. Morton, MS, Wilcox, G, Wahlqvist, ML, and Griffiths, K: Determination of lignans and isoflavonoids in human female plasma following dietary supplementation. J Endocrinol 142, 251-259, 1994.
34. Barnes, S, Sfakianos, J, Coward, L, and Kirk, M: Soy isoflavonoids and cancer prevention. Underlying biochemical and pharmacological issues. Adv Exp Med Biol 401, 87-100, 1996.
35. Gooderham, MJ, Adlercreutz, H, Ojala, ST, Wahala, K, and Holub, BJ: A soy protein isolate rich in genistein and daidzein and its effects on plasma isoflavone concentrations, platelet aggregation, blood lipids and fatty acid composition of plasma phospholipid in normal men. J Nutr 126, 2000-2006, 1996.
36. Freshney, RI: Quantitation and experimental design. In Culture of Animal Cells, 2nd ed, R Freshney (ed). New York: Liss, 1990, pp 227-244.
37. Axelson, M, Kirk, DN, Farrant, RD, Cooley, G, Lawson, AM, et al.: The identification of the weak oestrogen equol[7-hydroxy-3-(4′-hydroxyphenyl) chroman] in human urine. Biochem J 201, 353-357, 1982.
38. Axelson, M, Sjovall, J, Gustafsson, BE, and Setchell, KD: Soya - a dietary source of the nonsteroidal oestrogen equol in man and animals. J Endocrinol 102, 49-56, 1984.
39. So, FV, Guthrie, N, Chambers, AF, and Carroll, KK: Inhibition of proliferation of estrogen receptor-positive MCF-7 human breast cancer cells by flavonoids in the presence and absence of excess estrogen. Cancer Lett 112, 127-133, 1997.
40. Simons, SS, Jr: Environmental estrogens: can two "alrights" make a wrong? Science 272, 1451, 1996.
41. Dotzlaw, H, Leygue, E, Watson, PH, and Murphy, LC: Expression of estrogen receptor-β in human breast tumors. J Clin Endocrinol Metab 82, 2371-2374, 1997.
42. Witkowska, HE, Carlquist, M, Engstrom, O, Carlsson, B, Bonn, T, et al.: Characterization of bacterially expressed rat estrogen receptor-β ligand binding domain by mass spectrometry: structural comparison with estrogen receptor-α. Steroids 62, 621-631, 1997.
43. Kuiper, GG, Carlsson, B, Grandien, K, Enmark, E, Haggblad, J, et al.: Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors-α and -β. Endocrinology 138, 863-870, 1997.
44. Paech, K, Webb, P, Kuiper, GG, Nilsson, S, Gustafsson, J, et al.: Differential ligand activation of estrogen receptors ER-α and ER-β at AP1 sites. Science 277, 1508-1510, 1997.
45. Markaverich, BM, and Gregory, RR: Preliminary assessment of luteolin as an affinity ligand for type II estrogen-binding sites in rat uterine nuclear extracts. Steroids 58, 268-274, 1993.
46. Holland, MB, and Roy, D: Estrone-induced cell proliferation and differentiation in the mammary gland of the female Noble rat. Carcinogenesis 16, 1955-1961, 1995.
47. Mousavi, Y, and Adlercreutz, H: Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture. J Steroid Biochem Mol Biol 41, 615-619, 1992.
48. Stewart, AJ, Johnson, MD, May, FEB, and Westley, BR: Role of insulin-like growth factors and the type I insulin-like growth factor receptor in the estrogen-stimulated proliferation of human breast cancer cells. J Biol Chem 265, 21172-21178, 1990.
49. Stewart, AJ, Westley, BR, and May, FEB: Modulation of the proliferative response of breast cancer cells to growth factors by oestrogen. Br J Cancer 66, 640-648, 1992.
50. van der Burg, B, Isbrucker, L, van Selm-Miltenburg, AJP, de Laat, SW, and van Zoelen, EJJ: Role of estrogen-induced insulin-like growth factors in the proliferation of human breast cancer cells. Cancer Res 50, 7770-7774, 1990.
51. Panno, ML, Salerno, M, Pezzi, V, Sisci, D, Maggiolini, M, et al.: Effect of oestradiol and insulin on the proliferative pattern and on oestrogen and progesterone receptor contents in MCF-7 cells. J Cancer Res Clin Oncol 122, 745-749, 1996.
52. Pagliacci, MC, Smacchia, M, Migliorati, G, Grignani, F, Riccardi, C, et al.: Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells. Eur J Cancer 30A, 1675-1682, 1994.
53. Clark, JW, Santos-Moor, A, Stevenson, LE, and Frackelton, AR, Jr: Effects of tyrosine kinase inhibitors on the proliferation of human breast cancer cell lines and proteins important in the ras signaling pathway. Int J Cancer 65, 186-191, 1996.
54. Peterson, G, and Barnes, S: Genistein potently inhibits the growth of human primary breast epithelial cells: correlation with a lack of genistein metabolism (abstr). Mol Biol Cell 5, 384a, 1994.
55. Anderson, D, Dobrzynska, MM, and Basaran, N: Effect of various genotoxins and reproductive toxins in human lymphocytes and sperm in the comet assay. Teratog Carcinog Mutagen 17, 29-43, 1997.
56. Barnes, S, Peterson, TG, and Coward, L: Rationale for the use of genistein-containing soy matrices in chemoprevention trials for breast and prostate cancer. J Cell Biochem Suppl 22, 181-187, 1995.